UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000026693
Receipt number R000030647
Scientific Title The study of EPA's effects on coronary plaque inn patients with coronary heart diseases treated with PCI
Date of disclosure of the study information 2017/04/01
Last modified on 2017/03/24 20:22:40

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The study of EPA's effects on coronary plaque inn patients with coronary heart diseases treated with PCI

Acronym

The effects of EPA on coronary plaque

Scientific Title

The study of EPA's effects on coronary plaque inn patients with coronary heart diseases treated with PCI

Scientific Title:Acronym

The effects of EPA on coronary plaque

Region

Japan


Condition

Condition

coronary heart diseases

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The effects of EPA on coronary plaque

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Others

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

coronary plaque volume

Key secondary outcomes

clinical events


Base

Study type

Interventional


Study design

Basic design

Factorial

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

standard therapy

Interventions/Control_2

EPA administration

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

patients with stable coronary heart diseases treated with PCI

Key exclusion criteria

1) prior taking EPA, 2) recent acute coronary syndrome (< 1 year), 3) renal insufficiency (serum creatinine > 2.0 mg / dL), 4) hepatic dysfunction (serum AST or ALT > 3-folds of standard value), 5) cancer, 6) autoimmune diseases, 7) impossibility in decision making 8) consideration as inadequate to participating in the study by attending physician.

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Atsushi Katoh

Organization

Kurume University Medical Center

Division name

Cardiology

Zip code


Address

Kokubu-machi,Kurume, Fukuoka

TEL

0942-22-6111

Email

katou_atsushi@kurume-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Atsushi Katoh

Organization

Kurume University Medical Center

Division name

Cardiology

Zip code


Address

Kokubu-machi,Kurume, Fukuoka

TEL

0942-22-6111

Homepage URL


Email

katou_atsushi@kurume-u.ac.jp


Sponsor or person

Institute

Kurume University Medical Center

Institute

Department

Personal name



Funding Source

Organization

Kurume University Medical Center

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2011 Year 07 Month 22 Day

Date of IRB


Anticipated trial start date

2011 Year 08 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 03 Month 24 Day

Last modified on

2017 Year 03 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030647


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name